Nutrient Supplementation Strategies for Biopharmaceutical Production, Part 2 Feeding for Optimal Recombinant Protein Production

level: interMediAte Some of the numerous feeding strategies are more appropriate than others for certain types of cell culture production systems. Once a nutrient supplement has been identified as described in Part 1 of this three-part review (1), a supplementation strategy must be chosen. Supplementing at too great a rate may expose log-phase cells to stresses such as increased osmolality and lactate levels that would inhibit biomass expansion. But inadequate supplementation can lead to early apoptosis through rapid depletion of selected important components. For commercially available supplements, guidelines often suggest specific protocols that will usually yield good results and can be further optimized by subsequent experimentation. Additional culture-specific methods are available to laboratories with access to monitoring equipment. As mentioned in Part 1, monitoring one component is an excellent way of approaching relative nutrient homeostasis in the bioreactor, especially with stoichiometrically balanced nutrient supplements (1). They may be added semicontinuously (e.g., daily or twice daily), with each addition providing enough supplement to cover its expected consumption until the next addition. Supplements also can be added continually to match predicted consumption, but this approach is more generally applicable at the research scale than in commercial production. Supplementation of cell cultures generally refers to adding nutrients that replace those consumed, but another type of supplement can be considered. Cell metabolic pathways are important to optimizing protein expression because of the dichotomous pathway of biomass expansion and product synthesis. Cells that are expanding rapidly may not have the highest specific productivity (output per cell), but once maximum cell density is reached, specific productivity can peak and be held at high levels for extended periods of time. Nutrient supplements can be designed to promote both phases. So nutritional supplements (those containing major nutrients such as glucose and specific amino acids that are consumed during the expansion phase) represent one type of supplement. And metabolic supplements (those containing molecules to guide cells toward maximum productivity) represent the other type. Timing their addition may promote superior productivity. A number of molecules have been identified as helpful in the production phase of cell culture. When glucose is replaced by a more slowly metabolized hexose such as galactose or mannose, a slower metabolism results with correspondingly lowered lactic acid production. At the same time, inducers of protein synthesis such as butyrate and pentanoic acid can be used for switching cell machinery from further replication at the plateau phase into protein expression. Numerous small molecules are being researched as protein synthesis stimulators in high-throughput systems.

[1]  F. Wurm,et al.  Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. , 2008, Biotechnology and bioengineering.

[2]  A. Illanes,et al.  Analysis of CHO Cells Metabolic Redistribution in a Glutamate‐Based Defined Medium in Continuous Culture , 2001, Biotechnology progress.

[3]  Paul W. Sauer,et al.  A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies. , 2000, Biotechnology and bioengineering.

[4]  Raymond Davis,et al.  Identification of novel small molecule enhancers of protein production by cultured mammalian cells , 2008, Biotechnology and bioengineering.

[5]  Yan Wang,et al.  Improvement of Monoclonal Antibody Production in Hybridoma Cells by Dimethyl Sulfoxide , 2003, Biotechnology progress.

[6]  W. Bang,et al.  Enhanced production of recombinant B-domain deleted factor VIII from Chinese hamster ovary cells by propionic and butyric acids , 2003, Biotechnology Letters.

[7]  B. Kearns,et al.  Heuristic Optimization of Antibody Production by Chinese Hamster Ovary Cells , 2005, Biotechnology progress.

[8]  J. Auniņš,et al.  Large-scale mammalian cell culture. , 1997, Current opinion in biotechnology.

[9]  R. Senger,et al.  Optimization of fed‐batch parameters and harvest time of CHO cell cultures for a glycosylated product with multiple mechanisms of inactivation , 2007, Biotechnology and bioengineering.

[10]  J. Piret,et al.  Decreased pCO2 accumulation by eliminating bicarbonate addition to high cell‐density cultures , 2007, Biotechnology and bioengineering.

[11]  A. Gambhir,et al.  Alteration of cellular metabolism by consecutive fed-batch cultures of mammalian cells. , 1999, Journal of bioscience and bioengineering.

[12]  H. C. Hia,et al.  Effects of high concentrations of energy sources and metabolites on suspension culture of Chinese hamster ovary cells producing tissue plasminogen activator. , 2001, Journal of bioscience and bioengineering.

[13]  Wei-Shou Hu,et al.  Analysis of cellular metabolism of hybridoma cells at distinct physiological states. , 2003, Journal of bioscience and bioengineering.

[14]  A. Zeng,et al.  Variation of Stoichiometric Ratios and Their Correlation for Monitoring and Control of Animal Cell Cultures , 1998, Biotechnology progress.

[15]  Ray Field,et al.  Improved Fermentation Processes for NS0 Cell Lines Expressing Human Antibodies and Glutamine Synthetase , 2003, Biotechnology progress.

[16]  Weichang Zhou,et al.  Protein‐free fed‐batch culture of non‐GS NS0 cell lines for production of recombinant antibodies , 2007, Biotechnology and bioengineering.

[17]  Susan T Sharfstein,et al.  Sodium butyrate stimulates monoclonal antibody over-expression in CHO cells by improving gene accessibility. , 2008, Biotechnology and bioengineering.

[18]  Liangzhi Xie,et al.  Fed‐batch cultivation of animal cells using different medium design concepts and feeding strategies , 1994, Biotechnology and bioengineering.

[19]  Li Xie,et al.  Increasing the culture efficiency of hybridoma cells by the use of integrated metabolic control of glucose and glutamine at low levels , 2005, Biotechnology and applied biochemistry.

[20]  John Thrift,et al.  The "push-to-low" approach for optimization of high-density perfusion cultures of animal cells. , 2006, Advances in biochemical engineering/biotechnology.

[21]  J. Piret,et al.  Dependence on glucose limitation of the pCO2 influences on CHO cell growth, metabolism and IgG production , 2007, Biotechnology and bioengineering.

[22]  C. Goochee,et al.  Metabolism of PER.C6TM cells cultivated under fed‐batch conditions at low glucose and glutamine levels , 2006, Biotechnology and bioengineering.

[23]  I. Chu,et al.  Pentanoic acid, a novel protein synthesis stimulant for Chinese Hamster Ovary (CHO) cells. , 2001, Journal of bioscience and bioengineering.

[24]  Friedrich Srienc,et al.  Mammalian cell culture scale-up and fed-batch control using automated flow cytometry. , 2008, Journal of biotechnology.

[25]  G Stephanopoulos,et al.  Rapamycin reduces hybridoma cell death and enhances monoclonal antibody production. , 2001, Biotechnology and bioengineering.

[26]  F Gòdia,et al.  Strategies for fed-batch cultivation of t-PA producing CHO cells: substitution of glucose and glutamine and rational design of culture medium. , 2004, Journal of biotechnology.

[27]  J. Birch,et al.  The response of GS-NS0 myeloma cells to pH shifts and pH perturbations. , 2001, Biotechnology and bioengineering.

[28]  H. Prentice,et al.  Improving Performance of Mammalian Cells in Fed‐Batch Processes through “Bioreactor Evolution” , 2007, Biotechnology progress.

[29]  B. Buckland,et al.  Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. , 1997, Biotechnology and bioengineering.

[30]  Marina Etcheverrigaray,et al.  Impact of temperature reduction and expression of yeast pyruvate carboxylase on hGM-CSF-producing CHO cells. , 2004, Journal of biotechnology.

[31]  L. Häggström,et al.  Defined protein and animal component‐free NS0 fed‐batch culture , 2007, Biotechnology and bioengineering.

[32]  M. Yap,et al.  Enhancement of transient gene expression by fed-batch culture of HEK 293 EBNA1 cells in suspension , 2006, Biotechnology Letters.

[33]  G. Lee,et al.  Effect of Simultaneous Application of Stressful Culture Conditions on Specific Productivity and Heterogeneity of Erythropoietin in Chinese Hamster Ovary Cells , 2004, Biotechnology progress.

[34]  W M Miller,et al.  Phosphate feeding improves high-cell-concentration NS0 myeloma culture performance for monoclonal antibody production. , 2000, Biotechnology and bioengineering.

[35]  Wei-Shou Hu,et al.  Fedbatch culture and dynamic nutrient feeding. , 2006, Advances in biochemical engineering/biotechnology.

[36]  Yong-Ho Ahn,et al.  Effect of culture temperature on follicle-stimulating hormone production by Chinese hamster ovary cells in a perfusion bioreactor , 2007, Applied Microbiology and Biotechnology.

[37]  W M Miller,et al.  A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: Effect of nutrient concentration, dilution rate, and pH , 2000, Biotechnology and bioengineering.

[38]  Florian M. Wurm,et al.  Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives , 2007, Biotechnology Letters.

[39]  B. Kearns,et al.  Application of Fractional Factorial Designs to Screen Active Factors for Antibody Production by Chinese Hamster Ovary Cells , 2006, Biotechnology progress.

[40]  Yuanxing Zhang,et al.  Enhancement of hepatitis B surface antigen production by adenosine 5'-monophosphate in culture of recombinant Chinese hamster ovary cells. , 2005, Journal of bioscience and bioengineering.

[41]  F. Gòdia,et al.  Decoupling cell growth and product formation in Chinese hamster ovary cells through metabolic control. , 2001, Biotechnology and bioengineering.

[42]  G. Lee,et al.  Nutrient deprivation induces autophagy as well as apoptosis in Chinese hamster ovary cell culture , 2008, Biotechnology and bioengineering.

[43]  Zizhuo Xing,et al.  Identifying Inhibitory Threshold Values of Repressing Metabolites in CHO Cell Culture Using Multivariate Analysis Methods , 2008, Biotechnology progress.

[44]  Wei-Shou Hu,et al.  Low‐Glutamine Fed‐Batch Cultures of 293‐HEK Serum‐Free Suspension Cells for Adenovirus Production , 2003, Biotechnology progress.

[45]  S. R. Fox,et al.  Maximizing interferon‐γ production by chinese hamster ovary cells through temperature shift optimization: Experimental and modeling , 2004, Biotechnology and Bioengineering.

[46]  D. Fassnacht,et al.  Influence of non-essential amino acids on apoptotic and necrotic death of mouse hybridoma cells in batch cultures , 2004, Biotechnology Letters.

[47]  J. Lo,et al.  Glutamine or Glucose Starvation in Hybridoma Cultures Induces Death Receptor and Mitochondrial Apoptotic Pathways , 2006, Biotechnology Letters.